| Year |
Citation |
Score |
| 2023 |
Zhao N, Kabotyanski EB, Saltzman AB, Malovannaya A, Yuan X, Reineke LC, Lieu N, Gao Y, Pedroza DA, Calderon SJ, Smith AJ, Hamor CW, Safari K, Savage SR, Zhang B, ... ... Rosen JM, et al. Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer. The Journal of Clinical Investigation. PMID 37874652 DOI: 10.1172/JCI172503 |
0.352 |
|
| 2023 |
Zhao N, Kabotyanski EB, Saltzman AB, Malovannaya A, Yuan X, Reineke LC, Lieu N, Gao Y, Pedroza DA, Calderon SJ, Smith AJ, Hamor C, Safari K, Savage S, Zhang B, ... ... Rosen JM, et al. Targeting EIF4A triggers an interferon response to synergize with chemotherapy and suppress triple-negative breast cancer. Biorxiv : the Preprint Server For Biology. PMID 37808840 DOI: 10.1101/2023.09.28.559973 |
0.349 |
|
| 2023 |
Adewunmi O, Shen Y, Zhang XH, Rosen JM. Targeted inhibition of lncRNA Malat1 alters the tumor immune microenvironment in preclinical syngeneic mouse models of triple negative breast cancer. Cancer Immunology Research. PMID 37603945 DOI: 10.1158/2326-6066.CIR-23-0045 |
0.377 |
|
| 2022 |
Lin M, Ku AT, Dong J, Yue F, Jiang W, Ibrahim AA, Peng F, Creighton CJ, Nagi C, Gutierrez C, Rosen JM, Zhang XH, Hilsenbeck SG, Chen X, Du YN, et al. STAT5 confers lactogenic properties in breast tumorigenesis and restricts metastatic potential. Oncogene. PMID 36261627 DOI: 10.1038/s41388-022-02500-w |
0.309 |
|
| 2022 |
Si H, Zhao N, Pedroza A, Zaske AM, Rosen JM, Creighton CJ, Roarty K. Noncanonical Wnt/Ror2 signaling regulates cell-matrix adhesion to prompt directional tumor cell invasion in breast cancer. Molecular Biology of the Cell. mbcE22020055. PMID 36001375 DOI: 10.1091/mbc.E22-02-0055 |
0.347 |
|
| 2022 |
Singh S, Lee N, Pedroza DA, Bado IL, Hamor C, Zhang L, Aguirre S, Hu J, Shen Y, Xu Y, Gao Y, Zhao N, Chen SH, Wan YW, Liu Z, ... ... Rosen JM, et al. Chemotherapy coupled to macrophage inhibition induces T-cell and B-cell infiltration and durable regression in triple-negative breast cancer. Cancer Research. PMID 35442423 DOI: 10.1158/0008-5472.CAN-21-3714 |
0.317 |
|
| 2021 |
Janghorban M, Yang Y, Zhao N, Hamor C, Nguyen TM, Zhang XH, Rosen JM. Single Cell Analysis Unveils the Role of the Tumor Immune Microenvironment and Notch Signaling in Dormant Minimal Residual Disease. Cancer Research. PMID 34965936 DOI: 10.1158/0008-5472.CAN-21-1230 |
0.587 |
|
| 2021 |
Zhao N, Rosen JM. Breast cancer heterogeneity through the lens of single-cell analysis and spatial pathologies. Seminars in Cancer Biology. PMID 34274486 DOI: 10.1016/j.semcancer.2021.07.010 |
0.301 |
|
| 2021 |
Bowling EA, Wang JH, Gong F, Wu W, Neill NJ, Kim IS, Tyagi S, Orellana M, Kurley SJ, Dominguez-Vidaña R, Chung HC, Hsu TY, Dubrulle J, Saltzman AB, Li H, ... ... Rosen JM, et al. Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer. Cell. PMID 33450205 DOI: 10.1016/j.cell.2020.12.031 |
0.543 |
|
| 2020 |
Singh S, Zhang XHF, Rosen JM. TIME Is a Great Healer-Targeting Myeloid Cells in the Tumor Immune Microenvironment to Improve Triple-Negative Breast Cancer Outcomes. Cells. 10. PMID 33374595 DOI: 10.3390/cells10010011 |
0.323 |
|
| 2020 |
Nguyen TM, Alchalabi S, Oluwatoyosi A, Ropri AS, Herschkowitz JI, Rosen JM. New twists on long noncoding RNAs: from mobile elements to motile cancer cells. Rna Biology. 1-15. PMID 32522127 DOI: 10.1080/15476286.2020.1760535 |
0.528 |
|
| 2019 |
Nguyen TM, Kabotyanski EB, Reineke LC, Shao J, Xiong F, Lee JH, Dubrulle J, Johnson H, Stossi F, Tsoi PS, Choi KJ, Ellis AG, Zhao N, Cao J, Adewunmi O, ... ... Rosen JM, et al. The SINEB1 element in the long non-coding RNA Malat1 is necessary for TDP-43 proteostasis. Nucleic Acids Research. PMID 31863590 DOI: 10.1093/Nar/Gkz1176 |
0.504 |
|
| 2019 |
Kim IS, Gao Y, Welte T, Wang H, Liu J, Janghorban M, Sheng K, Niu Y, Goldstein A, Zhao N, Bado I, Lo HC, Toneff MJ, Nguyen T, Bu W, ... ... Rosen JM, et al. Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms. Nature Cell Biology. PMID 31451770 DOI: 10.1038/S41556-019-0373-7 |
0.515 |
|
| 2019 |
Soundararajan R, Fradette JJ, Konen JM, Moulder S, Zhang X, Gibbons DL, Varadarajan N, Wistuba II, Tripathy D, Bernatchez C, Byers LA, Chang JT, Contreras A, Lim B, Parra ER, ... ... Rosen JM, et al. Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy. Cancers. 11. PMID 31137625 DOI: 10.3390/Cancers11050714 |
0.324 |
|
| 2019 |
Vijay GV, Zhao N, Den Hollander P, Toneff MJ, Joseph R, Pietila M, Taube JH, Sarkar TR, Ramirez-Pena E, Werden SJ, Shariati M, Gao R, Sobieski M, Stephan CC, Sphyris N, ... ... Rosen JM, et al. GSK3β regulates epithelial-mesenchymal transition and cancer stem cell properties in triple-negative breast cancer. Breast Cancer Research : Bcr. 21: 37. PMID 30845991 DOI: 10.1186/S13058-019-1125-0 |
0.312 |
|
| 2018 |
Janghorban M, Xin L, Rosen JM, Zhang XH. Notch Signaling as a Regulator of the Tumor Immune Response: To Target or Not To Target? Frontiers in Immunology. 9: 1649. PMID 30061899 DOI: 10.3389/fimmu.2018.01649 |
0.394 |
|
| 2018 |
Nguyen TM, Kabotyanski EB, Dou Y, Reineke LC, Zhang P, Zhang XH, Malovannaya A, Jung SY, Mo Q, Roarty KP, Chen Y, Zhang B, Neilson JR, Lloyd RE, Perou CM, ... ... Rosen JM, et al. FGFR1-activated Translation of WNT Pathway Components with Structured 5' UTRs is Vulnerable to Inhibition of EIF4A-dependent Translation Initiation. Cancer Research. PMID 29844125 DOI: 10.1158/0008-5472.Can-18-0631 |
0.594 |
|
| 2018 |
Zhao N, Cao J, Xu L, Tang Q, Dobrolecki LE, Lv X, Talukdar M, Lu Y, Wang X, Hu DZ, Shi Q, Xiang Y, Wang Y, Liu X, Bu W, ... ... Rosen JM, et al. Pharmacological targeting of MYC-regulated IRE1/XBP1 pathway suppresses MYC-driven breast cancer. The Journal of Clinical Investigation. PMID 29480818 DOI: 10.1172/Jci95873 |
0.379 |
|
| 2017 |
Zhang P, He D, Xu Y, Hou J, Pan BF, Wang Y, Liu T, Davis CM, Ehli EA, Tan L, Zhou F, Hu J, Yu Y, Chen X, Nguyen TM, ... Rosen JM, et al. Genome-wide identification and differential analysis of translational initiation. Nature Communications. 8: 1749. PMID 29170441 DOI: 10.1038/S41467-017-01981-8 |
0.45 |
|
| 2017 |
Sreekumar A, Toneff MJ, Toh E, Roarty K, Creighton CJ, Belka GK, Lee DK, Xu J, Chodosh LA, Richards JS, Rosen JM. WNT-Mediated Regulation of FOXO1 Constitutes a Critical Axis Maintaining Pubertal Mammary Stem Cell Homeostasis. Developmental Cell. PMID 29103953 DOI: 10.1016/J.Devcel.2017.10.007 |
0.362 |
|
| 2017 |
Zhang M, Lee AV, Rosen JM. The Cellular Origin and Evolution of Breast Cancer. Cold Spring Harbor Perspectives in Medicine. PMID 28062556 DOI: 10.1101/cshperspect.a027128 |
0.318 |
|
| 2016 |
Welte T, Kim IS, Tian L, Gao X, Wang H, Li J, Holdman XB, Herschkowitz JI, Pond A, Xie G, Kurley S, Nguyen T, Liao L, Dobrolecki LE, Pang L, ... ... Rosen JM, et al. Erratum: Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nature Cell Biology. 18: 822. PMID 27350446 DOI: 10.1038/Ncb3379 |
0.536 |
|
| 2016 |
Welte T, Kim IS, Tian L, Gao X, Wang H, Li J, Holdman XB, Herschkowitz JI, Pond A, Xie G, Kurley S, Nguyen T, Liao L, Dobrolecki LE, Pang L, ... ... Rosen JM, et al. Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation. Nature Cell Biology. PMID 27183469 DOI: 10.1038/Ncb3355 |
0.578 |
|
| 2015 |
Zhang M, Rosen JM. Developmental Insights into Breast Cancer Intratumoral Heterogeneity. Trends in Cancer. 1: 242-251. PMID 26753176 DOI: 10.1016/j.trecan.2015.10.005 |
0.326 |
|
| 2015 |
Zhang M, Tsimelzon A, Chang CH, Fan C, Wolff A, Perou CM, Hilsenbeck SG, Rosen JM. Intratumoral heterogeneity in a Trp53-null mouse model of human breast cancer. Cancer Discovery. 5: 520-33. PMID 25735774 DOI: 10.1158/2159-8290.Cd-14-1101 |
0.319 |
|
| 2014 |
Wei W, Tweardy DJ, Zhang M, Zhang X, Landua J, Petrovic I, Bu W, Roarty K, Hilsenbeck SG, Rosen JM, Lewis MT. STAT3 signaling is activated preferentially in tumor-initiating cells in claudin-low models of human breast cancer. Stem Cells (Dayton, Ohio). 32: 2571-82. PMID 24891218 DOI: 10.1002/stem.1752 |
0.379 |
|
| 2014 |
Shore AN, Rosen JM. Regulation of mammary epithelial cell homeostasis by lncRNAs. The International Journal of Biochemistry & Cell Biology. 54: 318-30. PMID 24680897 DOI: 10.1016/j.biocel.2014.03.012 |
0.333 |
|
| 2013 |
Hollier BG, Tinnirello AA, Werden SJ, Evans KW, Taube JH, Sarkar TR, Sphyris N, Shariati M, Kumar SV, Battula VL, Herschkowitz JI, Guerra R, Chang JT, Miura N, Rosen JM, et al. FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer. Cancer Research. 73: 1981-92. PMID 23378344 DOI: 10.1158/0008-5472.Can-12-2962 |
0.376 |
|
| 2011 |
Batts TD, Machado HL, Zhang Y, Creighton CJ, Li Y, Rosen JM. Stem cell antigen-1 (sca-1) regulates mammary tumor development and cell migration. Plos One. 6: e27841. PMID 22140470 DOI: 10.1371/Journal.Pone.0027841 |
0.327 |
|
| 2011 |
Visbal AP, LaMarca HL, Villanueva H, Toneff MJ, Li Y, Rosen JM, Lewis MT. Altered differentiation and paracrine stimulation of mammary epithelial cell proliferation by conditionally activated Smoothened. Developmental Biology. 352: 116-27. PMID 21276786 DOI: 10.1016/J.Ydbio.2011.01.025 |
0.342 |
|
| 2010 |
Taube JH, Herschkowitz JI, Komurov K, Zhou AY, Gupta S, Yang J, Hartwell K, Onder TT, Gupta PB, Evans KW, Hollier BG, Ram PT, Lander ES, Rosen JM, Weinberg RA, et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proceedings of the National Academy of Sciences of the United States of America. 107: 15449-54. PMID 20713713 DOI: 10.1073/Pnas.1004900107 |
0.31 |
|
| 2010 |
Pond AC, Herschkowitz JI, Schwertfeger KL, Welm B, Zhang Y, York B, Cardiff RD, Hilsenbeck S, Perou CM, Creighton CJ, Lloyd RE, Rosen JM. Fibroblast growth factor receptor signaling dramatically accelerates tumorigenesis and enhances oncoprotein translation in the mouse mammary tumor virus-Wnt-1 mouse model of breast cancer. Cancer Research. 70: 4868-79. PMID 20501844 DOI: 10.1158/0008-5472.Can-09-4404 |
0.359 |
|
| 2010 |
Creighton CJ, Chang JC, Rosen JM. Epithelial-mesenchymal transition (EMT) in tumor-initiating cells and its clinical implications in breast cancer. Journal of Mammary Gland Biology and Neoplasia. 15: 253-60. PMID 20354771 DOI: 10.1007/S10911-010-9173-1 |
0.367 |
|
| 2010 |
Reddy JP, Peddibhotla S, Bu W, Zhao J, Haricharan S, Du YC, Podsypanina K, Rosen JM, Donehower LA, Li Y. Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation. Proceedings of the National Academy of Sciences of the United States of America. 107: 3728-33. PMID 20133707 DOI: 10.1073/Pnas.0910665107 |
0.332 |
|
| 2009 |
Heckman-Stoddard BM, Vargo-Gogola T, McHenry PR, Jiang V, Herrick MP, Hilsenbeck SG, Settleman J, Rosen JM. Haploinsufficiency for p190B RhoGAP inhibits MMTV-Neu tumor progression. Breast Cancer Research : Bcr. 11: R61. PMID 19703301 DOI: 10.1186/Bcr2352 |
0.321 |
|
| 2007 |
Xian W, Schwertfeger KL, Rosen JM. Distinct roles of fibroblast growth factor receptor 1 and 2 in regulating cell survival and epithelial-mesenchymal transition. Molecular Endocrinology (Baltimore, Md.). 21: 987-1000. PMID 17284663 DOI: 10.1210/Me.2006-0518 |
0.301 |
|
| 2007 |
Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA, Rosen JM. WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proceedings of the National Academy of Sciences of the United States of America. 104: 618-23. PMID 17202265 DOI: 10.1073/Pnas.0606599104 |
0.302 |
|
| 2006 |
Ginger MR, Shore AN, Contreras A, Rijnkels M, Miller J, Gonzalez-Rimbau MF, Rosen JM. A noncoding RNA is a potential marker of cell fate during mammary gland development. Proceedings of the National Academy of Sciences of the United States of America. 103: 5781-6. PMID 16574773 DOI: 10.1073/Pnas.0600745103 |
0.355 |
|
| 2005 |
Zhang M, Rosen JM. Stem cells in the etiology and treatment of cancer. Current Opinion in Genetics & Development. 16: 60-4. PMID 16377171 DOI: 10.1016/j.gde.2005.12.008 |
0.315 |
|
| 2005 |
Woodward WA, Chen MS, Behbod F, Rosen JM. On mammary stem cells. Journal of Cell Science. 118: 3585-94. PMID 16105882 DOI: 10.1242/Jcs.02532 |
0.325 |
|
| 2005 |
Li Y, Rosen JM. Stem/progenitor cells in mouse mammary gland development and breast cancer. Journal of Mammary Gland Biology and Neoplasia. 10: 17-24. PMID 15886883 DOI: 10.1007/S10911-005-2537-2 |
0.339 |
|
| 2005 |
Behbod F, Rosen JM. Will cancer stem cells provide new therapeutic targets? Carcinogenesis. 26: 703-11. PMID 15459022 DOI: 10.1093/carcin/bgh293 |
0.305 |
|
| 2003 |
Li Y, Welm B, Podsypanina K, Huang S, Chamorro M, Zhang X, Rowlands T, Egeblad M, Cowin P, Werb Z, Tan LK, Rosen JM, Varmus HE. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proceedings of the National Academy of Sciences of the United States of America. 100: 15853-8. PMID 14668450 DOI: 10.1073/Pnas.2136825100 |
0.367 |
|
| Show low-probability matches. |